$2.95+0.06 (+2.08%)
Sensus Healthcare, Inc.
Sensus Healthcare, Inc. in the Healthcare sector is trading at $2.95 with a market capitalization of $49M. Wall Street consensus targets $5.38 (4 analysts), implying a +82.2% move over the next 12 months. The stock is currently near its 52-week low of $2.66, remaining 18.7% below its 200-day moving average. On fundamentals, Piotroski 5/9 shows mixed financial quality, Altman Z in the safe zone. Risk note: MACD remains below its signal line. The Whystock Score of 80/100 reflects bullish alignment across trend, valuation and analyst targets.
| Metric (USD) | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Total Revenue | $2.29Mβ | $3.39Mβ | $4.94Mβ | $6.88Mβ | $7.32M |
| Gross Profit | $769,000β | $991,000β | $1.90Mβ | $2.71Mβ | $2.90M |
| Operating Income | -$3.18Mβ | -$4.36Mβ | -$3.15Mβ | -$2.57Mβ | -$1.94M |
| Net Income | -$8.75Mβ | -$2.63Mβ | -$3.17Mβ | -$943,000β | -$1.04M |
Sensus Healthcare, Inc. operates as a medical device company that manufactures and sells radiation therapy devices to healthcare providers worldwide. The company uses superficial radiation therapy, a low-energy X-ray technology in its portfolio of tr...